Huawen Li Selected Research

Bromodeoxyuridine (BrdU)

12/2018

Knockdown of NRSF inhibits cell proliferation of ovarian cancer via activating Hippo pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huawen Li Research Topics

Disease

6	Neoplasms (Cancer) 03/2023 - 10/2011
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2023 - 01/2012
3	Neoplasm Metastasis (Metastasis) 01/2012 - 08/2011
3	Leukemia 11/2011 - 07/2010
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2022
2	Breast Neoplasms (Breast Cancer) 10/2011 - 08/2011
1	Obesity 04/2024
1	Pelvic Organ Prolapse 10/2023
1	Endometrial Neoplasms (Endometrial Cancer) 03/2023
1	Atherosclerosis 02/2023
1	Insulin Resistance 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Adenocarcinoma 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Arsenic Poisoning 01/2020
1	Hyperglycemia 01/2019
1	Inflammation (Inflammations) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Hypoxia (Hypoxemia) 08/2012
1	Lymphatic Metastasis 10/2011
1	Hematologic Diseases (Blood Diseases) 07/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2009
1	Carcinoma (Carcinomatosis) 05/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
3	AntioxidantsIBA 04/2024 - 01/2019
2	ORALIT (ORS)IBA 01/2022 - 01/2022
2	3,4-dihydroxyphenylpyruvic acidIBA 01/2022 - 01/2022
2	3-(3,5-dihydroxyphenyl)-1-propanoic acidIBA 01/2022 - 01/2022
2	LuciferasesIBA 12/2018 - 10/2011
2	p38 Mitogen-Activated Protein KinasesIBA 08/2012 - 08/2011
2	Sodium-Hydrogen Exchanger 1IBA 01/2012 - 09/2011
1	coenzyme Q10 (CoQ10)IBA 04/2024
1	GlycolipidsIBA 04/2024
1	polycaprolactoneIBA 10/2023
1	Fibroins (Fibroin)IBA 10/2023
1	napabucasinIBA 03/2023
1	astaxanthine (astaxanthin)IBA 02/2023
1	Insulin (Novolin)FDA Link 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Coatomer Protein (Archain)IBA 01/2022
1	ParaffinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2020
1	Drinking WaterIBA 01/2020
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	Dimethyl FumarateIBA 01/2019
1	InterleukinsIBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Heme Oxygenase-1IBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 12/2018
1	RE1-silencing transcription factorIBA 12/2018
1	Superoxides (Superoxide)IBA 09/2017
1	Metformin (Glucophage)FDA LinkGeneric 02/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2012
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 12/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 08/2012
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Interleukin-8 (Interleukin 8)IBA 08/2012
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2012
1	cariporideIBA 11/2011
1	Sodium-Hydrogen ExchangersIBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2011
1	Lipocalin-2IBA 10/2011
1	Imatinib Mesylate (Gleevec)FDA Link 09/2011
1	MidkineIBA 07/2010
1	Rhodamine 123IBA 07/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009
1	Superoxide DismutaseIBA 05/2009
1	Peroxynitrous Acid (Peroxynitrite)IBA 05/2004

Therapy/Procedure

1	Subcutaneous Injections 11/2011
1	Therapeutics 10/2011